| 查看: 423 | 回复: 0 | |||
hekouyanlei铁杆木虫 (著名写手)
|
[交流]
SCI增刊《进化信息学》（Evolutionary bioinformatics in China ）期刊招客座编辑了
|
|
SCI增刊《进化信息学》（Evolutionary bioinformatics in China ）期刊招客座编辑了，有意联系hekouyanlei@gmail.com The supplement focusses on evolutionary bioinformatics in China. If you are interested in working with us on this important supplement please advise me within two days. Further information is available by email. The role You will be asked to solicit five papers for the supplement. You will also be able to submit a paper of your own, which if accepted for publication by the editor in chief will be published at no charge. Alternatively at your discretion this fee waiver may be allocated to another paper. Other papers will attract a 25 % discounted article processing fee if accepted for publication. At a later date you will be asked to contribute to the supplement’s editorial, along with the other guest editors. These tasks are not intended to require a significant amount of your time: almost all the administrative work will be undertaken by Libertas. For example you could provide us with a list of candidate authors and we would then undertake the communication on your behalf. Benefits for Guest Editors In recognition of the importance of their contribution we offer the following benefits to guest editors: · Recognition on the journal’s editorial board webpage and in the editorial · The opportunity to publish your own papers in a high visibility Pubmed indexed journal · Cultivate editorial experience · Collaborate with leading scholars working in the subject area. What to Do Next If this offer is potentially of interest please review the attached PDF: it provides more information on the supplement and the role and benefits of being a guest editor. If you decide you’d like to accept this offer please inform me within two days. Have a colleague who you’d like to recommend for this role? Please forward this email to your colleague and ask him or her to contact me as soon as possible. Thank you for your time. We are excited at this opportunity to work with you on this important effort. |
回复此楼» 猜你喜欢
宠物寄生虫防治：氟雷拉纳阻断GABA受体，持效12周驱杀跳蚤蜱虫
已经有0人回复
-
为呼吸打开通道：依伐卡托的科学之旅
已经有1人回复
-
化学工程及工业化学论文润色/翻译怎么收费?
已经有100人回复
-
Dordaviprone（ONC201）：小分子药物在中线胶质瘤中的应用
已经有0人回复
-
依喜替康：新型喜树碱衍生物的研究进展
已经有1人回复
-
膀胱癌靶向治疗新选择：厄达替尼作用机制与耐药研究进展
已经有0人回复
-
从水母到实验室：腔肠素的发现历程与生物发光奥秘
已经有1人回复
-
线粒体氧化磷酸化的新靶点：S-Gboxin的发现与研究进展
已经有0人回复
-
PROTAC药物开发选择VHL配体：MDK-7526以87%出口向量占有率成首选
已经有0人回复
-
MCC950：NLRP3炎症小体特异性抑制剂的科研应用与前景
已经有0人回复
-
康替唑胺研发17年：如何解决多重耐药菌感染难题
已经有0人回复